Invention Grant
- Patent Title: Compositions comprising anti-CEACAM1 and anti-PD antibodies for cancer therapy
-
Application No.: US15039022Application Date: 2014-11-25
-
Publication No.: US10081679B2Publication Date: 2018-09-25
- Inventor: Tehila Ben-Moshe , Yair Sapir , Ilana Mandel , Edna Meilin
- Applicant: CCAM BIOTHERAPEUTICS LTD.
- Applicant Address: IL Hod Hasharon
- Assignee: CCAM BIOTHERAPEUTICS LTD.
- Current Assignee: CCAM BIOTHERAPEUTICS LTD.
- Current Assignee Address: IL Hod Hasharon
- Agency: Rothwell Figg Ernst & Manbeck P.C.
- International Application: PCT/IL2014/051019 WO 20141125
- International Announcement: WO2015/075725 WO 20150528
- Main IPC: A61K39/395
- IPC: A61K39/395 ; C07K16/28 ; A61K35/17 ; A61K39/00 ; A61K35/12
Abstract:
The present invention provides compositions comprising anti-CEACAM1 antibodies, compositions comprising antibodies capable of inhibiting or blocking the interaction between PD-1 and its ligands, and methods for their combined use in treating cancer.
Public/Granted literature
- US20170166637A1 COMPOSITIONS COMPRISING ANTI-CEACAM1 AND ANTI-PD ANTIBODIES FOR CANCER THERAPY Public/Granted day:2017-06-15
Information query
